Intellectual Property India Publishes Patent Application for Sublingual Or Buccal Dosage Forms Comprising Antioxidants For Treatment Of Central Nervous System Disorders

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079982 A) filed by Beyond Barriers Therapeutics, Inc. on June 29, 2026, for Sublingual Or Buccal Dosage Forms Comprising Antioxidants For Treatment Of Central Nervous System Disorders.

Inventors include Kole, Ryan; Marshall, John; Polsky, Charles; Reinhardt, Brian; and Degregoris, Thomas A..

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: Sublingual or buccal dosage forms comprise at least one antioxidant compound, such as N-acetyl cysteine (NAC), or a pharmaceutically acceptable salt thereof. The sublingual or buccal dosage forms are administered for treating central nervous system (CNS) disorders, such as traumatic brain injury or stroke.

Disclaimer: Curated by HT Syndication.